D
Dyadic International, Inc. (DYAI)
NCM – Real Time Price. Currency in USD
0.72
+0.01 (0.79%)
At close: May 12, 2026, 4:00 PM EDT
0.70
-0.02 (-2.95%)
After-hours: May 12, 2026, 7:54 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.72
+0.01 (0.79%)
At close: May 12, 2026, 4:00 PM EDT
0.70
-0.02 (-2.95%)
After-hours: May 12, 2026, 7:54 PM EDT
Dyadic International, Inc., together with its subsidiaries, a biotechnology platform company, develops, manufactures, and commercializes proteins and enzymes in the United States. The company offers Dapibus Protein Production Platform, a proprietary expression system designed to produce non-animal proteins and enzymes for non-pharmaceutical markets, including life sciences, food and nutrition, and bio-industrial sector; and C1 Protein Production Platform, a thermophilic fungal platform for large-scale production of proteins. It has a research and development agreement with VTT Technical Research Centre of Finland, Ltd; license agreement with Rubic One Health to develop various livestock vaccines; and sub-license agreement with Phibro Animal Health/Abic Biological Laboratories to develop vaccines and treatments for livestock diseases. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.
| Name | Position |
|---|---|
| Mr. Joseph P. Hazelton | President & COO |
| Mr. Mark A. Emalfarb | Founder, CEO & Director |
| Ms. Ana Gómez Rodriguez | Secretary of the Board |
| Date | Type | Document |
|---|---|---|
| 2026-05-01 | PRE 14A | formpre14a.htm |
| 2026-04-30 | 10-K/A | form10-ka.htm |
| 2026-03-30 | 8-K | form8-k.htm |
| 2026-03-25 | 10-K | form10-k.htm |
| 2026-03-06 | 8-K | form8-k.htm |
| 2025-12-29 | 8-K | form8-k.htm |
| 2025-11-12 | 10-Q | form10-q.htm |
| 2025-10-07 | 8-K | form8-k.htm |
| 2025-09-16 | 8-K | form8-k.htm |
| 2025-08-13 | 8-K | form8-k.htm |